Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan vs placebo for aortic root dilatation in Marfan syndrome on beta-blockers
2007-005862-10Phase 3Completed
- Sponsor
- Ghent University Hospital
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Marfan syndrome (MFS) comparing Losartan + beta-blocker with Placebo + beta-blocker (2 arms). Primary endpoint: Rate of aortic root growth. Started Jan 2009; status: completed.
02
Drugs
losartan
03
Conditions
Marfan syndrome (MFS)
Beyond the preview
Go deeper on 2007-005862-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005862-10.